Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.
about
Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestationCurrent best practice in the management of hypertensive disorders in pregnancyEpidemiology of preeclampsia: impact of obesityAngiogenic factors in diagnosis, management, and research in preeclampsia.Preventing deaths due to the hypertensive disorders of pregnancyUsability and Feasibility of PIERS on the Move: An mHealth App for Pre-Eclampsia TriageThe XXI International Society of Hypertension in Pregnancy meeting, São Paulo, Brazil - A global health perspective.Strategies to reduce the global burden of direct maternal deaths.Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission.Correcting for optimistic prediction in small data setsCorrelation between pediatrician supply and public health in Japan as evidenced by vaccination coverage in 2010: secondary data analysis.Maternofoetal complications and their association with proteinuria in a tertiary care hospital of a developing country.Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? A retrospective cohort study.A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy.Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsiaPlacental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction.Unexpected random urinary protein:creatinine ratio results-limitations of the pyrocatechol violet-dye method.Association of proteinuria threshold in pre-eclampsia with maternal and perinatal outcomes: a nested case control cohort of high risk womenFirst-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women.Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsiaRisk of Adverse Pregnancy Outcomes in Women with CKD.Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.Hypertensive disorders of pregnancy: Case definitions & guidelines for data collection, analysis, and presentation of immunization safety data.Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.Ecalmpsia: maternal and fetal outcome.Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment for the exclusion of gestational hypertension and pre-eclampsia: a retrospective study in a university affiliated maternity hospitalPrediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models.Selecting candidate predictor variables for the modelling of post-discharge mortality from sepsis: a protocol development projectAcute myocardial infarction in the obstetric patient.Choosing outcomes in pregnancy researchCan adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trialMaternal near miss and death among women with severe hypertensive disorders: a Brazilian multicenter surveillance study.A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study.Adverse neonatal outcomes in women with pre-eclampsia in Mulago Hospital, Kampala, Uganda: a cross-sectional study.Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.The special programme of research in human reproduction: forty years of activities to achieve reproductive health for all.Clinical applications of biomarkers in preeclampsia.Pre-eclampsia: an update.
P2860
Q24201038-01CAC2A9-9D1D-40A0-AC96-934511B027BDQ26739585-418F0EDE-7394-42A1-8903-F39A4DFECB74Q27006497-7ED2A58D-E482-4889-83A7-AA16004F0E25Q27692060-B9D5278D-97D1-4032-848F-8417066E4E26Q28075616-D52FEF6A-E5B6-4D39-B595-9D9F1973FEB0Q28648136-9D14DB5D-C77F-45B6-B643-9577ED1C455FQ30061707-C6A8C072-567D-4DB2-964D-34CB70E4B8B3Q30061710-BB9FC36C-D20D-4EDC-9202-CBC53CBA46B5Q30573957-D7DF464D-40DB-491F-AF96-BF49731B8102Q30833438-5B3FDF77-6C06-4E0C-8301-40553B1C2A16Q30918240-6A589213-B511-48CA-A58C-18D6D550339DQ33415327-7781D12F-755C-4715-8BFA-FF06E4D55AFFQ33628500-36302CC8-0882-4615-8F11-F237660B0A57Q33844319-D8436242-44ED-472F-AC8B-BCB8981FAF99Q34119026-55F52AE3-FBF8-4513-8DDB-74587660A950Q34453242-8CE3F7B9-4C3B-4088-8D11-3A5A447D9A19Q34461130-1BDC370A-0569-4533-BA39-2ADFAB982DB0Q34500006-CD60704B-0D9B-4A9C-A26A-16E1DCD00260Q34832414-4312AAA9-1BC6-4C57-9127-DECC16768EB7Q35018462-EB4FBAB3-A0E5-45FE-891B-72782BBE17ECQ35067015-A83DA93A-FDE8-421F-B16B-2AA29772B3CAQ35871381-0388E41C-6152-46EC-A765-8CDCE45EBE34Q35903100-DDEB7FB0-9B8F-4119-84E8-087499A6BB1EQ36062460-BCD4E57B-6681-46FE-8D77-C6E428BDA239Q36079659-36DF64DF-8706-4906-8A07-2907F8499278Q36204596-326B7D29-F730-42CD-98EA-B5B7295AC290Q36292395-744BE265-7D8E-40C4-A66C-12FB05241D61Q36302931-759C5FF6-DFBA-4AAA-BD77-C48C5C19A561Q36327393-8D71F6B4-753D-442D-8872-280DCD1DDF87Q37025255-23EE764E-E0AB-4CD4-A48D-8EA1B22ECBE3Q37185920-B9064447-B3D7-4E19-80E8-1FB44BFC3779Q37185999-1E8337A0-2D42-426E-9033-CD53FF9835ECQ37252634-EF05F000-9935-454E-9283-A9373D98654BQ37497141-6B9FA805-60E2-4A1F-93CA-956A4A69053EQ37499137-1E812DD5-ECF7-4AAE-8A0C-EF3F21F5C10FQ37628221-6356C2AC-6128-4C2A-8A3F-D850236D9449Q37935034-F6881749-8EF1-4582-87D1-B94C23972AD0Q38059341-02B9E52C-D7B0-43EE-9EB0-21FD28F404B6Q38209381-6DACE3B6-F69D-45C5-94EA-8EE512CB02E2Q38219228-6F67D28C-7591-40B6-AF0D-7077A11874BF
P2860
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Prediction of adverse maternal ...... dation of the fullPIERS model.
@en
Prediction of adverse maternal ...... dation of the fullPIERS model.
@en-gb
Prediction of adverse maternal ...... dation of the fullPIERS model.
@nl
type
label
Prediction of adverse maternal ...... dation of the fullPIERS model.
@en
Prediction of adverse maternal ...... dation of the fullPIERS model.
@en-gb
Prediction of adverse maternal ...... dation of the fullPIERS model.
@nl
prefLabel
Prediction of adverse maternal ...... dation of the fullPIERS model.
@en
Prediction of adverse maternal ...... dation of the fullPIERS model.
@en-gb
Prediction of adverse maternal ...... dation of the fullPIERS model.
@nl
P2093
P50
P1433
P1476
Prediction of adverse maternal ...... dation of the fullPIERS model.
@en
P2093
Alexandra L Millman
Anne-Marie Côté
Annie B Ouellet
Barry N Walters
Beth Payne
Fiona Broughton Pipkin
Graeme N Smith
James A Russell
Jean-Marie Moutquin
Jennifer M Menzies
P304
P356
10.1016/S0140-6736(10)61351-7
P407
P577
2010-12-23T00:00:00Z